The bayou is home to Ghostwalker Wyatt Fontenot whose powers are both deadly and necessary for his survival as part of an elite and secret para military team. But when his home and family are threatened, Wyatt becomes the most dangerous thing in the bayou. At least until a sensual and mysterious woman called Pepper enters his life, needing him in more ways then either of them were prepared for. From #1 NY Times bestselling author Christine Feehan. Find out more at http://www.ChristineFeehan.com. Paranormal romance/fantasy/thriller
At 37 years old, with a thriving concrete business, a wife and three young children, dying was the last thing on Travis Roberts’ mind. But after a doctor’s visit for a kidney stone, Roberts learned he had cholangiocarcinoma, a cancer of the bile duct. His survival rate was zero.
Roberts shared his story as part of Northwestern Mutual’s ongoing Client Stories series, which highlights the importance of financial security in the face of life’s most difficult circumstances.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7100753-northwestern-mutual-financial-security-cancer-diagnosis-disability-insurance/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Did you use the plywood from your hurricane shutters to build a tree house or use your garage door brace to hold up the bird feeder? If so there’s a good chance your home may not be hurricane ready.
Being properly prepared is paramount during hurricane season. To learn more about how to protect yourself and your property, visit State Farm Learning Center. It can make a big difference to your safety, security and survival. Is your property hurricane ready?
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65822-state-farm-severe-weather-disaster-preparedness/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
Deciding to have a baby is a magical time in any hopeful soon-to-be parent’s life. However, it comes as no surprise that navigating those waters can also be stressful and filled with unknowns. What should be done prior to pregnancy? What changes will new mommy go through physically and emotionally? What steps can parents take prior to the baby’s arrival to make the transition more seamless?
The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers.
LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available.
In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available.
To view the multimedia release go to:
https://www.multivu.com/players/English/8284352-st-baldricks-foundation-conquer-childhood-cancers/
Most people are diligent when it comes to protecting our skin in the hot summer months. But, what about what’s literally closest to the sun… their hair?
Repeated exposure to sun, salt water, and chlorine chemical residues can take an unstylish toll on our tresses. By the end of the summer, heat, humidity, chlorine or salt water can dehydrate hair to the point where it looks and feels nearly fried. Add tight ponytails and braids, relaxers, color, heat, curlers and a few extra chemical “sun” streaks for style and you’ll definitely want to keep a “lid” on it… Your hair, that is.
Don’t despair—warm summer days don’t have to lead to thinning-damaged hair. Learn to love your summer hair with a few basic do’s and don’ts for nourished, healthy, thicker and fuller looking hair from BIOTA Botanicals.
To view the multimedia news release, go to http://www.multivu.com/players/English/7521351-biota-botanicals-summer-hair-beauty/
Clayton, one of America’s leading builders of prefabricated homes, has released a new video featuring the story of a family whose Clayton Built® home survived the devastating Category Four Hurricane Michael.
When the hurricane made landfall Oct.10, Darla and Terry’s Clayton Built® home was along its path. The two moved to Mexico Beach, Fla. from Alabama after retirement to be closer to the beach. They originally planned to build a site built home on their newly purchased property, but after learning more about Clayton and touring the company’s Clayton SE Homes home building facility in Addison, Ala., the couple opted to purchase a Clayton Built® home from Clayton Homes of Panama City instead.
To view the multimedia release go to:
https://www.multivu.com/players/English/8335052-clayton-built-home-mexico-beach-hurricane-michael/
